id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0032-0005,FDA,FDA-2010-E-0032,FDA/CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2011-08-08T04:00:00Z,2011,8,2011-08-08T04:00:00Z,,2011-08-08T19:12:38Z,,0,0,0900006480eda56c
FDA-2010-E-0032-0004,FDA,FDA-2010-E-0032,Determination of Regulatory Review Period for Purposes of Patent Extension: Stelara,Notice,N-Notice,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2010-12-06T17:40:07Z,2010-30512,0,0,0900006480baff07
FDA-2010-E-0032-0003,FDA,FDA-2010-E-0032,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-24T04:00:00Z,2010,3,2010-03-24T04:00:00Z,,2013-08-11T03:07:33Z,,0,0,0900006480ac7544
FDA-2010-E-0032-0001,FDA,FDA-2010-E-0032,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-07-27T23:04:32Z,,0,0,0900006480a7dde0
FDA-2010-E-0032-0002,FDA,FDA-2010-E-0032,Centocor Ortho Biotech Inc. - Patent Term Extension Application,Other,APP-Application,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-08-11T01:32:03Z,,0,0,0900006480a7dfa1